Museum specimens collected during a 1907 marine expedition reveal loss of genetic diversity in the Philippines

Joel Mokyr, Philippe Aghion, and Peter Howitt explained why the last two centuries have seen sustained economic growth rather than stagnation

A study could transform the lab study of olfaction—and may challenge a Nobel-winning hypothesis

Federal researchers confront growing uncertainty about future

Men-led papers receive more media coverage than women’s, new study finds

Japanese botanist Kenji Suetsugu studies plants that steal carbon and nutrients from soil fungi

Science chats with photographer Lindsey Wasson, who captured how Nobel winner Mary Brunkow reacted to life-changing news

Study identifies entirely new suite of enzymes that can make psilocybin

Researchers are testing multiple treatments for the rare genetic conditions

“Financial drubbing” underscores reliance of some independent research organizations on federal funding

PLOS, Frontiers, and others announce policies trying to stem the tide of suspect research

Some theorists think unusual event could be a black hole devouring a star from within

Swiss cheese materials called metal-organic frameworks can separate and store gases

Astronomers may have glimpsed a long-predicted wind of gas blowing out from Sagittarius A*

Surprising epigenetic effect relies on snippets of RNA packaged within sperm

Breakthrough paved the way to many of today’s budding quantum computers

Cascadia and San Andreas fault zones appear to generate synchronized earthquakes

Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi revealed how regulatory T cells prevent autoimmune disease

As government websites go dark, some nonprofits are trying to fill the void

DNA and historical sleuthing have traced the extinct bird’s remains to a museum in Ohio

The scientist and conservationist made waves with her observations and advocacy

AI promises advance warnings, and mathematical models point to a simple prevention strategy

Coalition that runs premier climate modeling center faces rising costs and budget uncertainty

Recent clinical successes, and profits, have prompted a rush among pharma companies to try new isotopes and targeting strategies